ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 859

Long-Term Outcomes of Renal Artery Involvement in Takayasu Arteritis

Seokchan Hong1, Oh Chan Kwon2, Byeongzu Ghang3, Yong-Gil Kim1, Chang-Keun Lee1 and Bin Yoo1, 1Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, 2Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, The Republic of, 3Division of Rheumatology, Department of Internal Medicine, Univerisy of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: hypertension, takayasu arteritis and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Vasculitis - Poster I: Large Vessel Vasculitis and Polymyalgia Rheumatica

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Long-term Outcomes of Renal Artery Involvement in Takayasu Arteritis

Background/Purpose: Takayasu arteritis (TA) involving the renal artery can result in hypertension, renal dysfunction, and premature death. Some patients with renal artery stenosis underwent revascularization procedures including stent insertion. The aim of this study was to investigate the long-term outcomes and factors that predict outcomes in TA patients with renal artery stenosis.

Methods: The medical records of patients diagnosed with TA between January 1997 and December 2014 were reviewed retrospectively. Renal artery involvement was based on CT and/or angiography findings. Poor outcome was defined as uncontrolled hypertension, chronic renal insufficiency, or death.

Results: Of the 62 TA patients with renal artery involvement, 11 (17.7%) underwent renal artery revascularization. Younger age, male gender, and more severe (>70%) stenosis were associated with vascular intervention. After a median follow-up of 90.6 months, 11 (17.7%) of the 62 patients had uncontrolled hypertension and six (9.7%) had chronic renal insufficiency, but these outcomes were not significantly associated with vascular intervention. Renal insufficiency (5/15 [33.3%] vs 3/47 [6.4%], p=0.016) and bilateral involvement (12/15 [80.0%] vs 23/47 [48.9%], p = 0.041) were significantly more frequent in patients with poor than good outcomes. Multivariate Cox analysis revealed that renal insufficiency at presentation (hazard ratio [HR]=13.778, 95% confidence interval [CI]=3.530–53.786; p=0.000) and bilateral renal artery involvement (HR=5.053, 95% CI=1.179–21.661; p=0.029) were significant risk factors for poor outcomes at follow-up, but revascularization procedure was not (HR=0.663, 95% CI=0.176–2.498; p=0.543) (Table 1).

Conclusion: Bilateral lesions and renal functional impairment at presentation, but not implementation of revascularization procedures, were significant factors for outcomes in TA patients with renal artery involvement.

Table 1. Multivariate analysis of clinical factors predictive of poor outcome in TA patients with renal artery involvement

HR 95% CI P-value
Renal impairment at presentationa 13.778 3.530–53.786 0.000
Bilateral involvement 5.053 1.179–21.661 0.029
Revascularization 0.663 0.176–2.498 0.543

aRenal insufficiency was defined as an estimated glomerular filtration rate < 60 ml/minute. CI: confidence interval; HR: hazard ratio.


Disclosure: S. Hong, None; O. C. Kwon, None; B. Ghang, None; Y. G. Kim, None; C. K. Lee, None; B. Yoo, None.

To cite this abstract in AMA style:

Hong S, Kwon OC, Ghang B, Kim YG, Lee CK, Yoo B. Long-Term Outcomes of Renal Artery Involvement in Takayasu Arteritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/long-term-outcomes-of-renal-artery-involvement-in-takayasu-arteritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/long-term-outcomes-of-renal-artery-involvement-in-takayasu-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology